Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT00190879 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

Start date: June 2005
Phase: Phase 4
Study type: Interventional

To investigate the effect of atomoxetine hydrochloride in treating adults who have attention deficit hyperactivity disorder with comorbid social anxiety disorder

NCT ID: NCT00186576 Completed - Clinical trials for Myelodysplastic Syndromes

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Start date: December 2001
Phase: N/A
Study type: Interventional

To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.

NCT ID: NCT00186472 Completed - Depression Clinical Trials

Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)

Start date: n/a
Phase: N/A
Study type: Interventional

Infants born premature face numerous medical problems, causing significant anxiety for their parents. Parents experience a range of negative emotions including concern for the health and well being of their fragile infant, guilt, and disappointment. Research has indicated that having an infant in the Neonatal Intensive Care Unit (NICU) is highly stressful for parents and multiple studies have demonstrated that parents can develop significant psychological reactions to this experience. Specifically, many parents develop clinically significant anxiety disorders such as acute stress disorder (ASD) and posttraumatic stress disorder (PTSD). This not only impacts the mental well-being of the parents, but also can lead to problems with the parent-infant relationship, and, in turn, negatively impact the infant and the family as a whole. Despite the reported negative effects parents experience due to the stress of having an infant on the NICU, surprisingly little research has examined how to reduce parents' symptoms of anxiety. Because parents play an essential role in the care of their infant after discharge from the NICU, treating the parent's emotional distress is highly important. The purpose of this study is to examine the efficacy of a cognitive-behaviorally based intervention in reducing parents' symptoms of anxiety associated with having an infant on the NICU. This treatment is modeled after treatments that have proven effective with parents of children with other types of medical problems, for example, parents of children with cancer. It is the hope of the investigators that this intervention will effectively reduce symptoms of anxiety of NICU parents as well as the likelihood of developing subsequent psychological disorders.

NCT ID: NCT00184418 Completed - Schizophrenia Clinical Trials

The Immune System and Psychiatric Disorders

Start date: January 2005
Phase: N/A
Study type: Observational

The study is based on a hypothesis that there is interaction between the activity in the immune system and in the mind. To study this, the investigators register different measures for activity in the immune system on patients unselectedly admitted to an acute psychiatric ward. The psychiatric statuses and diagnoses of these patients are carefully defined as well.

NCT ID: NCT00184379 Completed - Schizophrenia Clinical Trials

Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness

Start date: April 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of psychoeducation for relatives to patients with serious mental illness.

NCT ID: NCT00184314 Completed - Clinical trials for Eating Disorder Symptoms

Follow-up of Eating Disorder Patients From a 15-year Period.

Start date: March 2004
Phase: N/A
Study type: Observational

Retrospective follow-up study of former eating disorder patients in child- and adolescent psychiatry on psychiatric symptoms and social intelligence.

NCT ID: NCT00184301 Completed - Anorexia Nervosa Clinical Trials

A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.

Start date: September 2005
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether in-patient treatment is better then intensive out-patient group treatment for patients with concurrent eating disorder and personality disorder.

NCT ID: NCT00183716 Completed - Depression Clinical Trials

The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women

TREM
Start date: April 2004
Phase: Phase 3
Study type: Interventional

This study will determine the effectiveness of the Trauma Recovery and Empowerment Model in reducing the severity of post-traumatic stress disorder symptoms in women with mental disorders and who have experienced sexual or physical abuse.

NCT ID: NCT00183703 Completed - Bipolar Disorder Clinical Trials

Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder

Start date: July 2004
Phase:
Study type: Observational

This study will examine how various factors, such as psychiatric symptoms, gender, quality of life, and attitudes toward medication, affect treatment adherence in individuals with rapid cycling bipolar disorder.

NCT ID: NCT00182520 Completed - Clinical trials for Obsessive Compulsive Disorder

Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)

Start date: January 2002
Phase: Phase 4
Study type: Interventional

SRI's are considered first-line treatments for OCD, however many patients continue to have significant symptoms despite an adequate trial of an SRI. Neuroimaging studies have shown that the glutamate neurological system is involved in OCD. This study will test the safety and efficacy of topiramate, a drug, which targets glutamate, in the treatment of OCD, where the OCD has been un-responsive, or partially responsive to regular SRI treatment.